Elanco Announces Collaboration Agreement with Novozymes for Nutritional Health Innovation
Go back to Elanco Announces Collaboration Agreement with Novozymes for Nutritional Health Innovation| eLandia International, Inc. (NYSE: ELAN) | Delayed: 23.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.18 | 52 Week High | $0.65 | |||
| Open | $23.18 | 52 Week Low | $0.03 | |||
| Day High | $23.18 | P/E | N/A | |||
| Day Low | $23.18 | EPS | $-0.60 | |||
| Volume | 6,457 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1107.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1107.08 | 52 Week High | $88.16 | |||
| Open | $1107.08 | 52 Week Low | $67.88 | |||
| Day High | $1107.08 | P/E | 256.27 | |||
| Day Low | $1107.08 | EPS | $4.32 | |||
| Volume | 4,293 | |||||
